[Lioresal in the treatment of hemiplegia. Clinical and electromyographic evaluation. Preliminary report].
On the basis of an analysis of the clinical condition and electromyographic changes in 9 patients treated with Lioresal and 3 controls attention is called to the favourable effect of Lioresal in hemiparesis of cerebral origin. Lioresal was given in daily doses of 50 mg and no unfavourable side effects were observed. Reduction of muscular hypertonia and improvement of general motor activity was obtained.
D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000627:therapeutic use*; D001418:Baclofen / Q000627:therapeutic use*; D004361:Drug Tolerance; D004562:Electrocardiography; D004576:Electromyography; D005260:Female; D006429:Hemiplegia / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000613:Aminobutyrates; D001418:Baclofen
Kliniczna i elektromiograficzna ocena działania Lioresalu w niedowładach połowiczych. Doniesienie wstepne.